data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Immunic
(NASDAQ:IMUX)
$3.43
-0.51[-12.94%]
At close: Jun 29
$3.80
0.3700[10.79%]
After Hours: 4:11PM EDT
15 minutes delayed
Day High/Low3.35 - 3.91
52 Week High/Low2.52 - 14.5
Open / Close3.91 / -
Float / Outstanding29.9M / 30.5M
Vol / Avg.275.3K / 778.4K
Mkt Cap104.8M
P/E-
50d Avg. Price5.45
Div / Yield-
Payout Ratio-
EPS-0.74
Total Float29.9M

Immunic (NASDAQ:IMUX), Quotes and News Summary

Immunic (NASDAQ: IMUX)

Day High/Low3.35 - 3.91
52 Week High/Low2.52 - 14.5
Open / Close3.91 / -
Float / Outstanding29.9M / 30.5M
Vol / Avg.275.3K / 778.4K
Mkt Cap104.8M
P/E-
50d Avg. Price5.45
Div / Yield-
Payout Ratio-
EPS-0.74
Total Float29.9M
Benzinga - Jun 15, 2022, 6:33AM
Benzinga - Jun 3, 2022, 4:31AM
Benzinga - Jun 2, 2022, 3:48PM
Benzinga - Jun 2, 2022, 10:54AM
Benzinga - Jun 2, 2022, 6:33AM
Benzinga - May 18, 2022, 6:44AM
Benzinga - May 10, 2022, 10:38AM
Benzinga - May 10, 2022, 6:55AM
Benzinga - May 5, 2022, 6:46AM
Benzinga - May 4, 2022, 9:42AM
Benzinga - Mar 16, 2022, 6:36AM
Benzinga - Feb 28, 2022, 12:09PM
Benzinga - Feb 24, 2022, 6:45AM
Benzinga - Feb 18, 2022, 6:35AM
Benzinga - Feb 2, 2022, 4:13PM
load more
Sector: Health Care.Industry: Biotechnology
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-05
REV
Q1 2022Est.ActualSurprise
EPS-0.800-0.740 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Immunic Questions & Answers

Q
How do I buy Immunic (IMUX) stock?
A

You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Immunic's (IMUX) competitors?
Q
What is the target price for Immunic (IMUX) stock?
A

The latest price target for Immunic (NASDAQ: IMUX) was reported by SVB Leerink on Friday, June 3, 2022. The analyst firm set a price target for 9.00 expecting IMUX to rise to within 12 months (a possible 162.39% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Immunic (IMUX)?
A

The stock price for Immunic (NASDAQ: IMUX) is $3.43 last updated Today at June 29, 2022, 8:00 PM UTC.

Q
Does Immunic (IMUX) pay a dividend?
A

There are no upcoming dividends for Immunic.

Q
When is Immunic (NASDAQ:IMUX) reporting earnings?
A

Immunic’s Q2 earnings are confirmed for Friday, August 5, 2022.

Q
Is Immunic (IMUX) going to split?
A

There is no upcoming split for Immunic.

Q
What sector and industry does Immunic (IMUX) operate in?
A

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.